Astrazeneca Plc Adr Stock Analysis

AZN Stock  USD 67.75  0.51  0.75%   
AstraZeneca PLC ADR is undervalued with Real Value of 74.87 and Target Price of 83.71. The main objective of AstraZeneca PLC stock analysis is to determine its intrinsic value, which is an estimate of what AstraZeneca PLC ADR is worth, separate from its market price. There are two main types of AstraZeneca PLC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AstraZeneca PLC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AstraZeneca PLC's stock to identify patterns and trends that may indicate its future price movements.
The AstraZeneca PLC stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AstraZeneca PLC is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. AstraZeneca Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AstraZeneca PLC's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

AstraZeneca Stock Analysis Notes

About 17.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.88. AstraZeneca PLC ADR last dividend was issued on the 22nd of February 2024. The entity had 2:1 split on the 27th of July 2015. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 83100 people. For more info on AstraZeneca PLC ADR please contact Pascal Soriot at 44 20 3749 5000 or go to https://www.astrazeneca.com.

AstraZeneca PLC Quarterly Total Revenue

12.02 Billion

AstraZeneca PLC ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AstraZeneca PLC's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company has 28.62 B in debt with debt to equity (D/E) ratio of 0.89, which is OK given its current industry classification. AstraZeneca PLC ADR has a current ratio of 0.79, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity.
AstraZeneca PLC ADR has a very strong financial position based on the latest SEC filings
On 25th of March 2024 AstraZeneca PLC paid $ 0.985 per share dividend to its current shareholders
Latest headline from independent.co.uk: FTSE 100 treads water despite takeover news boosting two stocks

AstraZeneca PLC ADR Upcoming and Recent Events

Earnings reports are used by AstraZeneca PLC to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to AstraZeneca PLC previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

AstraZeneca Largest EPS Surprises

Earnings surprises can significantly impact AstraZeneca PLC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2002-10-24
2002-09-300.180.20.0211 
1999-10-29
1999-09-300.170.190.0211 
2005-04-28
2005-03-310.290.320.0310 
View All Earnings Estimates

AstraZeneca PLC Thematic Classifications

In addition to having AstraZeneca PLC stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Compulsion Idea
Compulsion
Addiction driven consumer products and services

AstraZeneca Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as AstraZeneca PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AstraZeneca PLC ADR backward and forwards among themselves. AstraZeneca PLC's institutional investor refers to the entity that pools money to purchase AstraZeneca PLC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Franklin Resources Inc2023-12-31
9.8 M
Atlantic Trust Group, Llc2023-09-30
9.5 M
Capital World Investors2023-12-31
9.3 M
Fisher Asset Management, Llc2023-09-30
9.2 M
Putnam Investments Llc2023-12-31
7.7 M
Blackrock Inc2023-09-30
6.4 M
Farallon Capital Management, L.l.c.2023-09-30
6.1 M
Nuveen Asset Management, Llc2023-09-30
5.3 M
Amvescap Plc.2023-09-30
4.9 M
T. Rowe Price Associates, Inc.2023-12-31
52.3 M
Wellington Management Company Llp2023-12-31
49.4 M
Note, although AstraZeneca PLC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AstraZeneca Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 210.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AstraZeneca Profitablity

AstraZeneca PLC's profitability indicators refer to fundamental financial ratios that showcase AstraZeneca PLC's ability to generate income relative to its revenue or operating costs. If, let's say, AstraZeneca PLC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AstraZeneca PLC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AstraZeneca PLC's profitability requires more research than a typical breakdown of AstraZeneca PLC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.17 %, which entails that for every 100 dollars of revenue, it generated $0.17 of operating income.
Last ReportedProjected for 2024
Return On Capital Employed 0.12  0.11 
Return On Assets 0.06  0.10 
Return On Equity 0.15  0.14 

Management Efficiency

AstraZeneca PLC ADR has Return on Asset of 0.066 % which means that on every $100 spent on assets, it made $0.066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1564 %, implying that it generated $0.1564 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Assets is likely to grow to 0.10, while Return On Capital Employed is likely to drop 0.11. At this time, AstraZeneca PLC's Asset Turnover is very stable compared to the past year.
Last ReportedProjected for 2024
Price Book Value Ratio 5.38  9.53 
Enterprise Value Multiple 16.76  9.84 
Price Fair Value 5.38  9.53 
The analysis of AstraZeneca PLC's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze AstraZeneca PLC's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of AstraZeneca Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0212
Forward Dividend Yield
0.0212
Forward Dividend Rate
1.45
Beta
0.173

Technical Drivers

As of the 29th of March, AstraZeneca PLC shows the Risk Adjusted Performance of 0.0336, downside deviation of 1.47, and Mean Deviation of 0.8964. AstraZeneca PLC ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for AstraZeneca PLC ADR, which can be compared to its rivals. Please confirm AstraZeneca PLC ADR variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if AstraZeneca PLC ADR is priced correctly, providing market reflects its regular price of 67.75 per share. Given that AstraZeneca PLC has jensen alpha of (0.06), we suggest you to validate AstraZeneca PLC ADR's prevailing market performance to make sure the company can sustain itself at a future point.

AstraZeneca PLC ADR Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AstraZeneca PLC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AstraZeneca PLC ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

AstraZeneca PLC Outstanding Bonds

AstraZeneca PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AstraZeneca PLC ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AstraZeneca bonds can be classified according to their maturity, which is the date when AstraZeneca PLC ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

AstraZeneca PLC Predictive Daily Indicators

AstraZeneca PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AstraZeneca PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

AstraZeneca PLC Corporate Filings

6K
25th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
19th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
14th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
12th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
7th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6th of March 2024
Certification of the accuracy of the financial statements and disclosures
ViewVerify
5th of March 2024
Other Reports
ViewVerify
6K
4th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

AstraZeneca PLC Forecast Models

AstraZeneca PLC's time-series forecasting models are one of many AstraZeneca PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AstraZeneca PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About AstraZeneca Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AstraZeneca PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AstraZeneca shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AstraZeneca PLC. By using and applying AstraZeneca Stock analysis, traders can create a robust methodology for identifying AstraZeneca entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin 0.15  0.20 
Operating Profit Margin 0.18  0.22 
Net Profit Margin 0.13  0.10 
Gross Profit Margin 0.82  0.87 

Current AstraZeneca Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AstraZeneca analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AstraZeneca analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
83.71Strong Buy13Odds
AstraZeneca PLC ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AstraZeneca analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AstraZeneca stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AstraZeneca PLC ADR, talking to its executives and customers, or listening to AstraZeneca conference calls.
AstraZeneca Analyst Advice Details

AstraZeneca Stock Analysis Indicators

AstraZeneca PLC ADR stock analysis indicators help investors evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By understating and applying AstraZeneca PLC stock analysis, traders can identify AstraZeneca PLC position entry and exit signals to maximize returns.
Begin Period Cash FlowB
Long Term Debt22.4 B
Common Stock Shares Outstanding3.1 B
Total Stockholder Equity39.1 B
Tax Provision938 M
Quarterly Earnings Growth Y O Y0.059
Property Plant And Equipment Net10.5 B
Cash And Short Term Investments5.9 B
Cash5.8 B
Accounts Payable3.3 B
Net Debt22.8 B
50 Day M A65.6704
Total Current Liabilities30.5 B
Other Operating Expenses37.1 B
Non Current Assets Total76.1 B
Forward Price Earnings16.2338
Non Currrent Assets Other1.1 B
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.